Swiss Childhood Health and Nutrition Survey (CHildHNS)

July 12, 2018 updated by: Isabelle Herter-Aeberli

National Studie Gesundheit Und Ernährung Von Primarschülern

The aim of the present study is to assess the prevalence of overweight and obesity in 6 to 12 year old children in Switzerland. This data will be used to investigate trends in the development of overweight and obesity in Switzerland. In addition, a questionnaire will be used to assess data on physical activity, nutrition, health and socioeconomic background and waist circumference as well as skin fold thicknesses will be measured.

Study Overview

Status

Completed

Study Type

Observational

Enrollment (Actual)

2292

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

2 years to 8 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

All children at the selected schools and in the defined age range are eligible.

Description

Inclusion Criteria:

  • age between 6 and 12 years

Exclusion Criteria:

  • none

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Cross-Sectional

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Prevalence of overweight and obesity
Time Frame: 1 day of first visit
Based on weight and height measurements BMI z-scores will be calculated for the classification in the different weight status groups (underweight, normal weight, overweight, obese)
1 day of first visit

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Waist circumference
Time Frame: 1 day of first visit
1 day of first visit
body fat %
Time Frame: 1 day of first visit
Based on the measurement of skinfold thicknesses at 4 sites body fat % will be calculated
1 day of first visit
Physical activity
Time Frame: 1 day of first visit
Assessed using a questionnaire
1 day of first visit
Nutrition
Time Frame: 1 day of first visit
Assessed using a questionnaire
1 day of first visit
General health
Time Frame: 1 day of first visit
Assessed using a questionnaire
1 day of first visit
Socioeconomic background
Time Frame: 1 day of first visit
Assessed using a questionnaire
1 day of first visit

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Age
Time Frame: 1 day of first visit
Assessed using a questionnaire
1 day of first visit
Gender
Time Frame: 1 day of first visit
Assessed using a questionnaire
1 day of first visit

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Isabelle Herter, PhD, ETH Zurich

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 17, 2017

Primary Completion (Actual)

March 31, 2018

Study Completion (Actual)

June 30, 2018

Study Registration Dates

First Submitted

August 18, 2017

First Submitted That Met QC Criteria

October 12, 2017

First Posted (Actual)

October 13, 2017

Study Record Updates

Last Update Posted (Actual)

July 13, 2018

Last Update Submitted That Met QC Criteria

July 12, 2018

Last Verified

July 1, 2018

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CHildHNS

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Overweight and Obesity in Schoolchildren

Subscribe